Literature DB >> 15920093

Mild, reversible pancytopenia induced by rosiglitazone.

Yoram Maaravi, Jochanan Stessman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920093     DOI: 10.2337/diacare.28.6.1536

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

1.  Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency.

Authors:  Philippe M Campeau; Olga Astapova; Rebecca Martins; Jean Bergeron; Patrick Couture; Robert A Hegele; Todd Leff; Claude Gagné
Journal:  J Lipid Res       Date:  2012-07-02       Impact factor: 5.922

Review 2.  Less known pathophysiological mechanisms of anemia in patients with diabetic nephropathy.

Authors:  M Pappa; E Dounousi; A Duni; K Katopodis
Journal:  Int Urol Nephrol       Date:  2015-05-28       Impact factor: 2.370

3.  Promise of endothelial progenitor cell for treatment of diabetic retinopathy.

Authors:  Ashay D Bhatwadekar; Lynn C Shaw; Maria B Grant
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01

4.  Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits.

Authors:  Sergio Li Calzi; Matthew B Neu; Lynn C Shaw; Maria B Grant
Journal:  EPMA J       Date:  2010-03-01       Impact factor: 6.543

5.  Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment.

Authors:  Olaia Naveiras; Valentina Nardi; Pamela L Wenzel; Peter V Hauschka; Frederic Fahey; George Q Daley
Journal:  Nature       Date:  2009-06-10       Impact factor: 49.962

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.